journal article·2022-06-24

Microfluidic Device-Enabled Mass Production of Lipid-Based Nanoparticles for Applications in Nanomedicine and Cosmetics

Yuka Matsuura-Sawada, Masatoshi Maeki, Takaaki Nishioka, Ayuka Niwa, Jun Yamauchi, Masashi Mizoguchi, Koichi Wada, Manabu Tokeshi

ACS Applied Nano Materials· Volume 5· Issue 6
Publisher page

Abstract

The preparation of lipid-based nanoparticles (LNPs) using microfluidic devices offers significant advantages, such as precise size control and easy scale-up, in a continuous manufacturing system. However, improvements in this preparation method are needed to enhance LNP productivity to meet commercial, such as clinical and consumer, demands. Feeding a highly concentrated lipid solution into microfluidic devices to obtain a high concentration of LNPs is one of the ways to boost productivity. However, this has not been investigated in detail because a high concentration of lipids in ethanol makes it difficult to control the size and dispersity of LNPs. We previously developed iLiNP, a microfluidic device with simple baffle mixer structures, which can achieve rapid ethanol dilution. The applicability of iLiNP for producing LNPs by feeding a highly concentrated lipid solution has not been investigated. Herein, we demonstrate the preparation of monodispersed LNPs using a highly concentrated lipid solution. We compare the performance of iLiNP with those of three commercially available microfluidic devices. The area of the aqueous–ethanol interface and the dilution rate of ethanol significantly affects the size controllability and dispersity of LNPs at high lipid concentrations. Compared with other microfluidic devices, iLiNP could produce smaller and more concentrated (particles/mL) LNPs. We show that by controlling the LNP size using microfluidic devices, especially iLiNP, it is possible to feed highly concentrated lipid solutions. This feature of iLiNP could be a time- and cost-saving option for the mass production of LNPs for application in nanomedicine and cosmetics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Microfluidic and Capillary Electrophoresis Applications · Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Graduate School of Chemical Sciences and Engineering, Hokkaido University, Kita 13 Nishi 8, Kita-ku, Sapporo 060-8628, Japan

Department of Chemistry, Manufacturing and Control, Kobe Pharma Research Institute, Nippon Boehringer Ingelheim Co., Ltd., 6-7-5 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan

Division of Applied Chemistry, Faculty of Engineering, Hokkaido University, Kita 13 Nishi 8, Kita-ku, Sapporo 060-8628, Japan

JST PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan

Funding

Hokkaido University · Ministry of Education, Culture, Sports, Science and Technology · Core Research for Evolutional Science and Technology · Precursory Research for Embryonic Science and Technology · Japan Agency for Medical Research and Development · Japan Society for the Promotion of Science · Iketani Science and Technology Foundation

References (35)

Show source-provided references
1. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
2. 10.1007/s40265-016-0538-710.1007/s40265-016-0538-7 ↗
3. 10.1080/17425247.2019.166955810.1080/17425247.2019.1669558 ↗
4. 10.1093/annonc/mdh09710.1093/annonc/mdh097 ↗
5. 10.1002/jcph.155310.1002/jcph.1553 ↗
6. 10.1002/jcph.148010.1002/jcph.1480 ↗
7. 10.1007/s40265-021-01480-710.1007/s40265-021-01480-7 ↗
8. 10.1016/j.ijpharm.2021.12058610.1016/j.ijpharm.2021.120586 ↗
9. Roberts S. A. · J. Liposome Res. · 2017 · 28 · 1
10. 10.1021/acsbiomaterials.7b0057210.1021/acsbiomaterials.7b00572 ↗
11. 10.1016/j.addr.2020.07.00210.1016/j.addr.2020.07.002 ↗
12. 10.1016/j.jconrel.2022.02.01710.1016/j.jconrel.2022.02.017 ↗
13. 10.1021/acsomega.8b0034110.1021/acsomega.8b00341 ↗
14. 10.1371/journal.pone.018796210.1371/journal.pone.0187962 ↗
15. 10.1039/C4LC00334A10.1039/C4LC00334A ↗
16. 10.1021/nn901676x10.1021/nn901676x ↗
17. 10.1016/j.addr.2018.03.00810.1016/j.addr.2018.03.008 ↗
18. 10.3791/6299910.3791/62999 ↗
19. 10.1021/acsami.0c0548910.1021/acsami.0c05489 ↗
20. 10.1021/ar010110q10.1021/ar010110q ↗
21. 10.1039/D0RA08826A10.1039/D0RA08826A ↗
22. 10.3390/polym1211257210.3390/polym12112572 ↗
23. 10.1016/j.jcis.2004.10.01410.1016/j.jcis.2004.10.014 ↗
24. 10.3390/ma1012141110.3390/ma10121411 ↗
25. 10.3390/pharmaceutics1211100110.3390/pharmaceutics12111001 ↗
26. 10.1002/smll.20150134510.1002/smll.201501345 ↗
27. 10.1016/j.cej.2013.04.05310.1016/j.cej.2013.04.053 ↗
28. 10.1039/b923299k10.1039/b923299k ↗
29. 10.1038/s41598-020-62500-210.1038/s41598-020-62500-2 ↗
30. Webb C. · Pharm. · 2019 · 11 · 653
31. 10.1016/j.tibtech.2013.05.00410.1016/j.tibtech.2013.05.004 ↗
32. 10.1016/j.nano.2011.04.00310.1016/j.nano.2011.04.003 ↗
33. 10.1186/1743-422X-9-26510.1186/1743-422X-9-265 ↗
34. 10.1007/s11051-020-04840-810.1007/s11051-020-04840-8 ↗
35. 10.1021/acs.iecr.9b0407910.1021/acs.iecr.9b04079 ↗